MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Harvard Bioscience Company Profile (NASDAQ:HBIO)

Consensus Ratings for Harvard Bioscience (NASDAQ:HBIO) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.00 (69.49% upside)

Analysts' Ratings History for Harvard Bioscience (NASDAQ:HBIO)
Show:
DateFirmActionRatingPrice TargetActions
10/30/2015Benchmark Co.Lower Price TargetBuy$8.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014Alere FinancialInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014Janney Montgomery ScottInitiated CoverageBuy -> Buy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha